hemotune raises CHF 5.1 million Series A funding

12-08-2020 – hemotune announced today that its spin-off hemotune AG has successfully closed their 5.1 million Series A funding round. The fundraising aims to advance the development of HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads.

Wysszurich keyvisual hemotune

Despite the corona crisis, hemotune managed to build a very strong consortium led by OCCIDENT with participation of the Korean medical device company Green Cross Medical Science Corp. (GCMS), and Zürcher Kantonalbank.